JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB312465

Alexa Fluor® 568 Anti-Dcp1a antibody [EPR13822]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal DCP1A antibody - conjugated to Alexa Fluor® 568.

View Alternative Names

SMIF, DCP1A, mRNA-decapping enzyme 1A, Smad4-interacting transcriptional co-activator, Transcription factor SMIF

  • Unconjugated

    Anti-Dcp1a antibody [EPR13822]

  • 660 APC

    APC Anti-Dcp1a antibody [EPR13822]

  • HRP

    HRP Anti-Dcp1a antibody [EPR13822]

  • 578 PE

    PE Anti-Dcp1a antibody [EPR13822]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-Dcp1a antibody [EPR13822]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Dcp1a antibody [EPR13822]

  • Carrier free

    Anti-Dcp1a antibody [EPR13822] - BSA and Azide free

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Dcp1a antibody [EPR13822]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Dcp1a antibody [EPR13822]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Dcp1a antibody [EPR13822]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR13822

Isotype

IgG

Conjugation

Alexa Fluor® 568

Excitation/Emission

Ex: 578nm, Em: 603nm

Carrier free

No

Applications

Target Binding Affinity, Antibody Labelling

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Product details

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: 68% PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay (PubMed : 12417715). Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP (PubMed : 12417715). Contributes to the transactivation of target genes after stimulation by TGFB1 (PubMed : 11836524). Essential for embryonic development (PubMed : 33813271).
See full target information DCP1A

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Version
Primary Antibodies

AB240275

Anti-Dcp1a antibody [EPR13822] - BSA and Azide free

primary-antibodies

dcp1a-antibody-epr13822-bsa-and-azide-free-ab240275

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com